ArticleInorganic chemistry2026
Controlling Nanoscale Compositional Inhomogeneities to Enhance Tb3+ Luminescence in YVO4 Nanocrystals.
Article in Inorganic chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Controlling chemical homogeneity during aqueous coprecipitation of oxide nanoparticles remains challenging due to unintended byproducts that impact the microstructure and functionality of the final materials. Hence, precise tuning of structural, optical, and catalytical properties requires not only accurate knowledge of how such impurities evolve under annealing, but also effective strategies for defect engineering. Here, we demonstrate how hydroxylation and carbonation affect the internal structure and optical properties of YVO4 nanoparticles synthesized using different vanadate precursors. The use of highly basic Na3VO4 promotes unintentional carbonation, leading to Y/V nonstoichiometry and formation of the yttrium-rich Y8V2O17 secondary phase upon annealing. Combined in situ and ex situ characterizations further reveal that CO32- and OH- species embedded in the particle structure induce thermally driven nanovoids and reshape the local defect structure of the solids. More importantly, we expand defect engineering in YVO4:Tb3+ nanoparticles by intentional hydroxylation and carbonation to enhance luminescence intensities. Adjusting these compositional defects enables us to modulate the energy of metal-metal charge transfer (MMCT) deactivation pathways, resulting in up to 13-fold higher emission intensity compared to chemically pure YVO4:Tb3+. These findings establish defect incorporation as an effective route for tailoring the optical response of rare-earth vanadate nanoparticles, opening new opportunities for advanced photonic and luminescent sensing applications.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.